Association between the progression of immunoglobulin A nephropathy and a controlled status of hypertension in the first year after diagnosis
Tae Ryom Oh, Hong Sang Choi, Se Won Oh, Jieun Oh, Dong Won Lee, Chang Seong Kim, Seong Kwon Ma, Soo Wan Kim, Eun Hui Bae,
Korean J Intern Med. 2022;37(1):146-153. Published online 2021 Apr 8 DOI: https://doi.org/10.3904/kjim.2020.205
Citations to this article as recorded by 
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases
Sahar H. Koubar, Alejandro Garcia-Rivera, Muner M. B. Mohamed, John E. Hall, Michael E. Hall, Mohamed Hassanein
Current Hypertension Reports.2024; 26(3): 119. CrossRef
Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy
Daniel C. Cattran, Jürgen Floege, Rosanna Coppo
Kidney International Reports.2023; 8(12): 2515. CrossRef
Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection
Kailong Wang, Zhikai Yu, Yinghui Huang, Ke Yang, Ting He, Tangli Xiao, Yanlin Yu, Yan Li, Liang Liu, Jiachuan Xiong, Jinghong Zhao
Journal of Nephrology.2021; 34(6): 1887. CrossRef